Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 1.1 | 1.1 | 0.9 | 31.6 | 6.4 | 2.7 |
| Revenue growth | 0.0% | 22.6% | -97.3% | 391.0% | 134.5% | |
| Cost of goods sold | -40.9 | -54.8 | -49.4 | 0.0 | 0.0 | 0.0 |
| Gross profit | 41.9 | 55.9 | 50.2 | 31.6 | 6.4 | 2.7 |
| Gross margin | 3937.6% | 5245.2% | 5781.2% | 100.0% | 100.0% | 100.0% |
| Sales and marketing | 1.7 | 1.9 | 0.8 | 0.9 | 0.5 | 0.2 |
| Research and development | 14.6 | 20.9 | 20.0 | 12.9 | | |
| General and administrative | 5.2 | 5.6 | 4.8 | 2.0 | 1.6 | 1.2 |
| EBIT | 20.4 | 27.4 | 24.7 | 15.8 | 4.4 | 1.3 |
| EBIT margin | 1918.8% | 2572.6% | 2840.6% | 50.0% | 67.6% | 49.0% |
| Pre-tax income | 23.2 | 25.5 | 24.6 | 18.8 | 7.8 | 4.1 |
| Income taxes | 0.0 | -0.4 | -0.4 | -0.2 | -0.1 | 0.0 |
| Net income | 23.2 | 25.9 | 25.0 | 19.0 | 7.9 | 4.1 |
| Net margin | 2178.9% | 2429.0% | 2873.5% | 60.3% | 122.1% | 148.6% |
| |
| Diluted EPS | $0.95 | $1.59 | $2.36 | $37.93 | | |
| Shares outstanding (diluted) | 24.4 | 16.3 | 10.6 | 0.5 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|